Immunoassay Market by Product (Kits and Reagents, Analyzers, Software), Platform (Chemiluminescence, Radioimmunoassays) Application (Infectious Diseases, Cardiology), End User (Hospitals, Academic Laboratories), and Geography - Global Forecast to 2025

  • Report ID:MRHC - 104278
  • Pages: 221
  • Jul 2019
  • Formats*: PDF
  • Category: Healthcare

1. Introduction
    1.1. Market Definition
    1.2. Market Segmentation
    1.3. Currency and Limitations
           1.3.1. Currency
           1.3.2. Limitations
    1.4. Key Stakeholders

2. Research Methodology
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.2. Primary Research
           2.1.3. Market Size Estimation

3. Executive Summary
    3.1. Introduction
    3.2. Market Dynamics
    3.3. Product Segment Analysis
    3.4. Platforms Segment Analysis
    3.5. Application Analysis
    3.6. End User Analysis
    3.7. Regional Analysis
    3.8. Competitive Analysis

4. Market Insights
    4.1. Market Overview
    4.2. Drivers
           4.2.1. Increasing Incidence of Chronic Diseases and Infectious Diseases
           4.2.2. Increasing Use of Immunoassays in Oncology
           4.2.3. Vital Role of Immunoassays in Drug and Alcohol Testing
           4.2.4. Technological Advancements in Immunoassay
    4.3. Restraints
           4.3.1. Limitations of Immunoassay
    4.4. Opportunities
           4.4.1. Growth Opportunities in Emerging Economies
           4.4.2. Increasing Epidemic Potentials

5. Global Immunoassay Market, by Product
    5.1. Overview
    5.2. Immunoassay Kits and Reagents
           5.2.1. Rapid Test Kits and Reagents
           5.2.2. Elisa Kits and Reagents
           5.2.3. Western Blot Kits and Reagents
           5.2.4. Elispot Kits and Reagents
           5.2.5. Other Immunoassay Kits and Reagents
    5.3. Immunoassay Analyzers
    5.4. Immunoassay Software and Services

6. Global Immunoassay Market, by Platforms
    6.1. Overview
    6.2. Chemiluminescence Immunoassays
    6.3. Fluorescence Immunoassays
    6.4. Colorimetric Immunoassays
    6.5. Radioimmunoassays
    6.6. Other Immunoassay Platforms

7. Global Immunoassay Market, by Application
    7.1. Overview
    7.2. Infectious Diseases
    7.3. Cardiology
    7.4. Endocrinology
    7.5. Oncology
    7.6. Bone and Mineral Diseases
    7.7. Autoimmune Disease
    7.8. Allergy
    7.9. Other Applications

8. Global Immunoassay Market, by End User
    8.1. Overview
    8.2. Hospitals and Clinics
    8.3. Clinical Laboratories
    8.4. Blood Banks
    8.5. Pharmaceutical and Biotechnology Companies
    8.6. Academic & Research Institutions
    8.7. Other End Users

9. Immunoassay Market, by Geography
    9.1. Overview
    9.2. North America
           9.2.1. U.S.
           9.2.2. Canada
    9.3. Europe
           9.3.1. Germany
           9.3.2. Italy
           9.3.3. France
           9.3.4. Spain
           9.3.5. U.K.
           9.3.6. Rest of Europe
    9.4. Asia Pacific
           9.4.1. China
           9.4.2. Japan
           9.4.3. India
           9.4.4. Rest of Asia Pacific
    9.5. Latin America
    9.6. Middle East & Africa

10. Competitive Landscape
      10.1. Overview
      10.2. Market Share Analysis
      10.3. Competitive Situations and Trends
               10.3.1. New Product Launches
               10.3.2. Approvals
               10.3.3. Acquisitions
               10.3.4. Partnerships, Agreements, and Collaborations
               10.3.5. Expansions

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Recent Developments)
      11.1. Abbott Laboratories
      11.2. F. Hoffmann-La Roche AG
      11.3. Siemens AG
      11.4. Danaher Corporation
      11.5. DiaSoin S.p.A
      11.6. Sysmex Corporation
      11.7. bioMérieux SA
      11.8. Qiagen N.V.
      11.9. Thermo Fisher Scientific
      11.10. Agilent Technologies

12. Appendix
      12.1. Questionnaire
      12.2. Available Customization

List of Tables

Table 1 Currency Conversion Rates for USD
Table 2 Global Immunoassays Market Size, by Product, 2017–2025 ($Million)
Table 3 Immunoassays Market Size, by Country/Region, 2017–2025 ($Million)
Table 4 Types of Reagents Used to Carry Out the Immunoassays
Table 5 Immunoassay Kits and Reagents Market Size, by Type, 2017–2025 ($Million)
Table 6 Immunoassay Kits and Reagents Market Size, by Country/Region, 2017–2025 ($Million)
Table 7 Key Commercial Rapid Test Kits and Reagents in Market
Table 8 Rapid Test Kits and Reagents Market Size, by Country/Region, 2017–2025 ($Million)
Table 9 Key Commercial Elisa Test Kits and Reagents in Market
Table 10 Elisa Kits and Reagents Market Size, by Country/Region, 2017–2025 ($Million)
Table 11 Western Blot Kits and Reagents Market Size, by Country/Region, 2017–2025 ($Million)
Table 12 Key Commercial Elispot Kits in Market
Table 13 Elispot Kits and Reagents Market Size, by Country/Region, 2017–2025 ($Million)
Table 14 Other Immunoassay Kits and Reagents Market Size, by Country/Region, 2017–2025 ($Million)
Table 15 Key Commercial Immunoassay Analyzers in Market
Table 16 Immunoassay Analyzers Market Size, by Country/Region, 2017–2025 ($Million)
Table 17 Key Commercial Immunoassay Software in Market
Table 18 Immunoassay Software and Services Market Size, by Country/Region, 2017–2025 ($Million)
Table 19 Global Immunoassay Market Size, by Platforms, 2017–2025 ($Million)
Table 20 Chemiluminescence Immunoassays Market Size, by Country/Region, 2017–2025 ($Million)
Table 21 Fluorescence Immunoassay Market Size, by Country/Region, 2017–2025 ($Million)
Table 22 Colorimetric Immunoassay Market Size, by Country/Region, 2017–2025 ($Million)
Table 23 Radioimmunoassays Market Size, by Country/Region, 2017–2025 ($Million)
Table 24 Other Immunoassay Platforms Market Size, by Country/Region, 2017–2025 ($Million)
Table 25 Global Immunoassay Market Size, by Application, 2017–2025 ($Million)
Table 26 Immunoassay Market Size for Infectious Diseases, by Country/Region, 2017–2025 ($Million)
Table 27 Immunoassay Market Size for Cardiology, by Country/Region, 2017–2025 ($Million)
Table 28 Immunoassay Market Size for Endocrinology, by Country/Region, 2017–2025 ($Million)
Table 29 Immunoassay Market Size for Oncology, by Country/Region, 2017–2025 ($Million)
Table 30 Immunoassay Market Size for Bone and Mineral Diseases, by Country/Region, 2017–2025 ($Million)
Table 31 Immunoassay Market Size for Autoimmune Diseases, by Country/Region, 2017–2025 ($Million)
Table 32 Immunoassay Market Size for Allergy, by Country/Region, 2017–2025 ($Million)
Table 33 Immunoassay Market Size for Other Applications, by Country/Region, 2017–2025 ($Million)
Table 34 Global Immunoassay Market Size, by End User, 2017–2025 ($Million)
Table 35 Immunoassays Market Size for Hospitals, by Country/Region, 2017–2025 ($Million)
Table 36 Immunoassays Market Size for Clinical Laboratories, by Country/Region, 2017–2025 ($Million)
Table 37 Immunoassays Market Size for Blood Banks, by Country/Region, 2017–2025 ($Million)
Table 38 Immunoassays Market Size for Pharmaceutical and Biotechnology Companies, by Country/Region, 2017–2025 ($Million)
Table 39 Immunoassays Market Size for Academic and Research Institutions, by Country/Region, 2017–2025 ($Million)
Table 40 Immunoassay Market Size for Others End User, by Country/Region, 2017–2025 ($Million)
Table 41 Immunoassays Market Size, by Region, 2017–2025 ($Million)
Table 42 North America: Immunoassays Market Size, by Country, 2017–2025 ($Million)
Table 43 North America: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 44 North America: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 45 North America: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 46 North America: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 47 North America: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 48 U.S.: Immunoassays Market, by Type Size, 2017–2025 ($Million)
Table 49 U.S.: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 50 U.S.: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 51 U.S.: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 52 U.S.: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 53 Canada: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 54 Canada: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 55 Canada: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 56 Canada: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 57 Canada: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 58 Europe: Immunoassays Market Size, by Country, 2017–2025 ($Million)
Table 59 Europe: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 60 Europe: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 61 Europe: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 62 Europe: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 63 Europe: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 64 Germany: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 65 Germany: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 66 Germany: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 67 Germany: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 68 Germany: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 69 Italy: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 70 Italy: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 71 Italy: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 72 Italy: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 73 Italy: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 74 France: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 75 France: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 76 France: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 77 France: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 78 France: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 79 Spain: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 80 Spain: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 81 Spain: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 82 Spain: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 83 Spain: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 84 U.K.: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 85 U.K.: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 86 U.K.: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 87 U.K.: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 88 U.K.: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 89 Rest of Europe: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 90 Rest of Europe: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 91 Rest of Europe: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 92 Rest of Europe: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 93 Rest of Europe: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 94 Asia Pacific: Immunoassays Market Size, by Country, 2017–2025 ($Million)
Table 95 Asia Pacific: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 96 Asia Pacific: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 97 Asia Pacific: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 98 Asia Pacific: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 99 Asia Pacific: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 100 China: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 101 China: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 102 China: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 103 China: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 104 China: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 105 Japan: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 106 Japan: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 107 Japan: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 108 Japan: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 109 Japan: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 110 India: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 111 India: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 112 India: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 113 India: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 114 India: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 115 Rest of Asia Pacific: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 116 Rest of Asia Pacific: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 117 Rest of Asia Pacific: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 118 Rest of Asia Pacific: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 119 Rest of Asia Pacific: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 120 Latin America: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 121 Latin America: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 122 Latin America: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 123 Latin America: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 124 Latin America: Immunoassays Market Size, by End User, 2017–2025 ($Million)
Table 125 Middle East & Africa: Immunoassays Market Size, by Type, 2017–2025 ($Million)
Table 126 Middle East & Africa: Immunoassay Kits & Reagents Market Size, by Type, 2017–2025 ($Million)
Table 127 Middle East & Africa: Immunoassays Market Size, by Platforms, 2017–2025 ($Million)
Table 128 Middle East & Africa: Immunoassays Market Size, by Application, 2017–2025 ($Million)
Table 129 Middle East & Africa: Immunoassays Market Size, by End User, 2017–2025 ($Million)

List of Figures

Figure 1 Key Stakeholders in the global Immunoassay Market
Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Global Immunoassays Market Size Forecast, 2017–2025 ($Million)
Figure 6 Immunoassays Product: Global Market Outlook, 2019 Vs. 2025
Figure 7 Immunoassay Kits & Reagents Type: Global Market Outlook, 2019 Vs. 2025
Figure 8 Immunoassays Platform: Global Market Outlook, 2019 Vs. 2025
Figure 9 Immunoassays Application: Global Market Outlook, 2019 Vs. 2025
Figure 10 Immunoassays End User: Global Market Outlook, 2019 Vs. 2025
Figure 11 Immunoassays Regional Analysis: Global Market Outlook, 2019 Vs. 2025
Figure 12 Market Dynamics
Figure 13 Key Market Drivers
Figure 14 Cancer Incidence and Mortality
Figure 15 Per Capita Healthcare Expenditure in Emerging Countries (USD)
Figure 16 Global Immunoassay Market Size, by Product, 2019–2025 ($Million)
Figure 17 Global Immunoassay Market Size, by Platforms, 2019–2025 ($Million)
Figure 18 Cancer Incidence, by Type (2018)
Figure 19 Global Immunoassay Market Size, by Application, 2019–2025 ($Million)
Figure 20 Global Immunoassay Market Size, by End User, 2019–2025 ($Million)
Figure 21 Rising Medicare Reimbursement
Figure 22 Immunoassay Market Size, by Region, 2019–2025 ($Million)
Figure 23 U.S. Healthcare Spending ($Billion)
Figure 24 Canada: Geriatric Population (Million)
Figure 25 Canada: Cancer Incidences, by Type (2015)
Figure 26 Europe: Highest Share of Geriatric Population, 2010-2019
Figure 27 Key Strategy Adopted by the Key Players in the Market: Product Launch and Approvals
Figure 28 Product Portfolio Analysis
Figure 29 Immunoassays Market Share Analysis, by Key Players, 2018 (%)
Figure 30 R&D Expenditure of Key Players in Immunoassays Market
Figure 31 Abbott Laboratories: Financial Overview (2016-2018)
Figure 32 F. Hoffmann-La Roche AG: Financial Overview (2016-2018)
Figure 33 Siemens AG: Financial Overview (2016-2018)
Figure 34 Danaher Corporation: Financial Overview (2016-2018)
Figure 35 DiaSoin S.p.A: Financial Overview (2015-2017)
Figure 36 Sysmex Corporation: Financial Overview (2016-2018)
Figure 37 bioMerieux SA: Financial Overview (2015-2017)
Figure 38 QIAGEN N.V.: Financial Overview (2015-2017)
Figure 39 Thermo Fisher Scientific: Financial Overview (2016-2018)
Figure 40 Agilent Technologies: Financial Overview (2016-2018)

The global immunoassay market is expected to grow at a CAGR of 5.9% from 2019 to reach $19.76 billion by 2025. Immunoassays can be defined as a chemical test used to detect or quantify a specific substance using an immunological reaction. Due to the use of antibodies and purified antigens, immunoassays are very sensitive and specific. The molecule detected by the immunoassay is often referred to as an analyte and is in many cases a protein, although it may be other kinds of molecules, of different size and types, as long as the proper antibodies that have the adequate properties for the assay are developed. Immunoassays are utilized in healthcare industry in applications such as infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, and neonatal screening. Increasing incidences of chronic and infectious diseases, increasing use of immunoassay in oncology, rise in drug and alcohol testing, and technological advancement in immunoassay are the major factors driving the growth of overall immunoassay market.

Increasing Incidence of Chronic and Infectious Diseases Fuels the Growth of the Global Immunoassay Market

With rapid globalization and flow of populations from one region to another, the risk of spreading infectious diseases has also increased over the years. On the other hand, the globalization has also led to changing lifestyle of populations, leading to growing prevalence of lifestyle diseases and chronic diseases. Historically, infectious diseases have been one of the most important contributors to human morbidity. The WHO projected that by 2020, chronic diseases would account for almost three-quarters of all deaths worldwide, of which nearly 71% of deaths due to ischaemic heart disease, 75% due to stroke, and 70% due to diabetes will be in developing countries. As early detection of infectious and chronic diseases can save millions of lives, the immunoassay technologies are increasingly becoming the standard way of diagnosis for various diseases. With the factors such as rapid turnaround time and generally high specificity, immunoassays are increasingly becoming available for point-of-care testing for infectious diseases.

Immunoassay Market 2025 by Meticulous Research

Click here to: Get Free Request Sample Copy of this report

Increasing Use of Immunoassay in Oncology Supports the Market Growth

The prevalence and incidence of cancer cases is dramatically increasing globally, thus the application of immunoassay for early diagnosis and monitoring of cancer is growing gradually.

  • According to GLOBOCAN 2018, incidence rate of cancer has increased from 14.1 million in 2012 to 15.2 million in 2015 to 17.0 million in 2018 with a rise of about 12%. Moreover, the mortality due to cancer has also witnessed a rise from 8.2 million deaths in 2012 to 9.4 million deaths in 2018.
  • According to American Cancer Society, lung cancer is one of the most common forms of cancer. In 2018, nearly 2.09 million people across the globe were living with lung cancer, and according to the WHO this number is expected to increase 2.27 million by 2020. Clinical laboratories play a key role in the early detection of cancer, which drives the course of successful treatment.

In addition, oncology biomarkers can provide affordable, reliable, accurate, non-invasive, and sensitive information to help effectively manage cancer. Moreover, the awareness for early detection of cancer is increasing with positive results in 5-year relative survival rates in early detected localized lung, colorectal or breast cancer patients.

Technological Advancements in Immunoassay

Immunoassays have been one of the fast-growing clinical diagnostics technologies over the years. The technological advancements in immunoassays driven by the need for early detection of diseases have supported their adoption over the years, and hence have supported the immunoassay market growth. Today, with the development of excellent methods of signal generation, the attention has shifted to the development of immunochemical methods and instruments to provide convenient high-performance systems. Important advances have been made in the design of immunochemical approaches that allow small molecules, such as drugs, metabolites and toxins, to substitute dynamic format assays with non-competitive formats, bringing advantages previously seen only with large molecular analytes. Bispecific antibodies and recombinant proteins are also beginning to provide an impact upon immunodiagnostics, with the promise of reagents which are even more particular. Through all these advances, the usage of immunoassays is further expected to expand, in turn supporting the market growth.

Key Findings in the Global Immunoassay Market Study:

Rapid Test Kits & Reagents to Post the Fastest Growth

Increasing demand for rapid diagnostic tests in decentralized healthcare delivery settings, along with rising awareness regarding early diagnosis among people are some of the key factors driving the growth of the rapid test kits and reagents market. In addition, the escalating need for inexpensive diagnostic testing coupled with improving accuracy of advanced rapid diagnostic tests are also supporting the immunoassay market growth. Some of the major rapid test kits and reagents available in the market include cardiac marker testing kits, pregnancy testing kits, urine rapid testing kits, infectious disease testing kits, allergy testing kits, tumor marker testing kits, and drugs of abuse testing kits, among others. High prevalence of infectious diseases across the globe, rapidly increasing geriatric population, growing usage of home-based lateral flow assay test, and growing demand for point-of-care testing are expected to boost the growth of rapid test kits and reagents market during the forecast period.

Radioimmunoassay Platforms to Grow at the Highest CAGR

Radioimmunoassays have wide applications in cancer detection, blood screening for hepatitis, diagnosis of ulcers, and narcotics detection. These assays are capable of quantification of very small concentrations of antigens from small volumes of samples (as low as one-trillionth of a gram per milliliter of blood) with the help of radioisotopes, such as iodine-125 and iodine-131. The growth in this immunoassay market is primarily driven by the increasing prevalence of cancer across the globe and resultant increase in suitable diagnostic technologies. However, these assays are relatively high cost assays and have potential health hazards owing to use of radioactive antigens. This, along with additional expenses towards maintaining radiation safety and disposal protocols limit their wide-scale use. Owing to these, radioimmunoassays are increasingly being replaced by EIAs and CLIAs, which is expected to hamper the growth of the radioimmunoassay market over the coming years.

Hospital and Clinics to Witness the Largest Demand Through 2025

The hospitals segment accounted for the largest share of the global immunoassay market in 2018 and is expected to grow at the highest CAGR during the forecast period. Hospital-based laboratories conduct tests on samples collected from patients and also work as reference laboratories for smaller hospitals, physician offices, and community clinics. Compared to reference laboratories, hospital laboratories are easily accessible and provide test results in less time. Rising number of private hospitals in the emerging countries coupled with the large pool of patient population is driving the market for immunodiagnostics/immunoassays. For instance, according to the Commonwealth Fund, the total number of hospitals in China has increased significantly over the last decade from roughly 18,700 in 2005 to about 27,600 hospitals in 2015 and further increased to 31,056 in 2017. In addition to the above factors, the growing patient population, rising Medicare reimbursement for clinical tests performed in hospitals, emergence of advanced diagnostic tests, and improving healthcare infrastructure are the key factors driving the growth of immunoassay market among hospitals.

Asia Pacific: The Fastest Growing Regional Market

The immunoassay market in Asia Pacific, especially in China, India, and Japan is expected to witness high growth during the forecast period. The growth in this market is expected to be driven by large pool of patient population, increasing prevalence of infectious diseases and cancer, increasing government spending on the healthcare, and growing disposable income of the population that improved the access to diagnosis and treatment. In addition, favorable government policies and structural healthcare reforms are further expected to drive the market growth. Furthermore, lack of stringent regulations and liberalization in Asian countries is also a key factor making Asia Pacific a lucrative market.

Immunoassay Market Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (January 2016- May 2019). The key players profiled in the global immunoassay market research report are F. Hoffman La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux (France), Ortho Clinical Diagnostics (U.S.), DiaSorin SPA (Italy), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Merck (Germany), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer (U.S.), Quidel Corporation (U.S.), Bio-Techne Corporation (U.S.), and Mindray (China) among others.

Scope of Immunoassay Market Report:

Immunoassay Market by Product

  • Immunoassay Kits & Reagents
    • Rapid Test Reagents & Kits
    • Elisa Reagents & Kits
    • Western Blot Reagents & Kits
    • Elispot Reagents & Kits
    • Other Reagents & Kits
  • Immunoassay Analyzers
  • Immunoassay Software & Services

Immunoassay Market by Platforms

  • Chemiluminescence Immunoassays
  • Fluorescence Immunoassays
  • Colorimetric Immunoassays
  • Radioimmunoassays
  • Other Platforms

Immunoassay Market by Application

  • Infectious Diseases
  • Cardiology
  • Endocrinology
  • Oncology
  • Bone & Mineral Disorders
  • Autoimmune Disorders
  • Allergy
  • Other Applications

Immunoassay Market by End User

  • Hospitals & Clinics
  • Clinical Laboratories/Reference Labs
  • Blood Banks
  • Pharmaceutical and Biotechnology Companies
  • Research & Academic Laboratories
  • Other End Users

Immunoassay Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in Immunoassay Market report:

Hospitals and clinics accounted for the largest share of the immunoassay market globally

  • What factors contribute to the frequent usage of immunoassay products and platforms in hospitals & clinics?
  • Which geographic segment is expected to experience the fastest growth in the usage of immunoassay products in hospitals & clinics, clinical laboratories/reference laboratories, blood banks, pharmaceutical and biotechnology companies, and other end users?
  • How does the penetration of immunoassay products in hospitals & clinics differ from other end users?

Immunoassay market favours both regional and local manufacturers that compete in multiple segments

  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies looking to enter in this market use to compete effectively?
  • What are the major drivers, restraints, opportunities, and challenges in the immunoassay market?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the geographical trends and high growth regions/ countries?

Recent strategic developments taken place in the immunoassay market

  • What technological advancements have taken place in this industry?
  • Which companies are recently merged/acquired by prominent players in this market and how will these unions affect the competitive landscape?
  • Who are the major players in the global immunoassay market and what shares of the market do they hold?
  • hat are the local emerging players in this market and how do they compete with the global players?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: In Vitro Diagnostics Immunoassays Assays Reagents
Download Free Sample
to